Diagnostic Approach to High Proinsulin with Low Glucose and Normal Insulin/C-peptide
Pathophysiology and Diagnostic Significance
- The persistence of inappropriately increased plasma insulin concentrations with low glucose concentration strongly suggests the presence of an islet cell tumor 1
- An increase in the ratio of fasting proinsulin to insulin in an individual with hypoglycemia is particularly suggestive of an islet cell tumor 1
- Normal C-peptide levels with elevated proinsulin may indicate a defect in the conversion of proinsulin to insulin, which can occur in certain islet cell tumors 2
Differential Diagnosis
- Insulinomas are characterized by inappropriate insulin secretion with elevated proinsulin levels 3
- Genetic abnormalities that result in the inability to convert proinsulin to insulin can be inherited in an autosomal dominant pattern 2
- Mutations in proinsulin processing enzymes can lead to high proinsulin with normal insulin levels 2
- Surreptitious insulin administration can be ruled out by measuring C-peptide, which would be low or suppressed with exogenous insulin administration 1, 4
Diagnostic Approach
- The proinsulin-to-insulin ratio is typically elevated in insulinomas and can be used as a diagnostic tool 1
- A 72-hour supervised fast with measurements of blood glucose, insulin, C-peptide, and proinsulin can help confirm hypoglycemia with inappropriate insulin/proinsulin secretion 3
Management Considerations
- Surgical treatment is recommended for localized insulinomas, with a cure rate of approximately 90% 3
- Preoperative stabilization of blood glucose through dietary measures and/or diazoxide may be necessary 3
- Caution is advised when using somatostatin analogs due to potential worsening of hypoglycemia 3
Important Clinical Pearls
- The absence of changes in glucose, insulin, and proinsulin concentrations in an individual with fasting hypoglycemia makes the diagnosis of an islet cell tumor unlikely 1
- Measurement of C-peptide is essential in investigating nondiabetic hypoglycemia to rule out hypoglycemia due to surreptitious insulin administration 1, 4